Close menu



Bevacizumab - Labelled (Arg,Lys) 13C15N


Quantification of Bevacizumab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Bevacuzimab is a full length, recombinant, stable isotope labelled IgG1 monoclonal antibody designed for use as an internal standard for quantitative analysis of Bevacuzimab in plasma samples. Bevacuzimab inhibits the biologic activity of human vascular endothelial growth factor (VEGF) and is used to treat a range of cancers.

This product is for research use only and is not intended for diagnostic or therapeutic use.